These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16982748)

  • 41. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
    Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
    Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
    Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
    Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.
    Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L
    Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
    Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
    J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
    Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
    Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
    J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
    Deftos LJ; Barken I; Burton DW; Hoffman RM; Geller J
    Biochem Biophys Res Commun; 2005 Feb; 327(2):468-72. PubMed ID: 15629138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells.
    Thebault S; Flourakis M; Vanoverberghe K; Vandermoere F; Roudbaraki M; Lehen'kyi V; Slomianny C; Beck B; Mariot P; Bonnal JL; Mauroy B; Shuba Y; Capiod T; Skryma R; Prevarskaya N
    Cancer Res; 2006 Feb; 66(4):2038-47. PubMed ID: 16489003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of calcium-sensing receptor in rat colonic epithelium: evidence for modulation of fluid secretion.
    Cheng SX; Okuda M; Hall AE; Geibel JP; Hebert SC
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G240-50. PubMed ID: 12065312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].
    Luo Y; He DL; Ning L
    Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NPC-14686 (Fmoc-l-homophenylalanine)-induced CaCa2+ increases and death in human prostate cancer cells.
    Huang JK; Liu CS; Chen WC; Liu SI; Hsu SS; Chang HT; Chou CT; Hsieh CH; Chang CH; Jan CR
    Life Sci; 2006 Jan; 78(9):964-9. PubMed ID: 16188277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of calcium-sensing receptor in inhibition of lipolysis through intracellular cAMP and calcium pathways in human adipocytes.
    He Y; Zhang H; Teng J; Huang L; Li Y; Sun C
    Biochem Biophys Res Commun; 2011 Jan; 404(1):393-9. PubMed ID: 21130730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphoprotein associated with glycosphingolipid microdomains 1 inhibits the proliferation and invasion of human prostate cancer cells in vitro through suppression of Ras activation.
    Yu W; Wang Y; Gong M; Pei F; Zheng J
    Oncol Rep; 2012 Aug; 28(2):606-14. PubMed ID: 22664862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of econazole on Ca2+ levels in and the growth of human prostate cancer PC3 cells.
    Huang JK; Liu CS; Chou CT; Liu SI; Hsu SS; Chang HT; Hsieh CH; Chang CH; Chen WC; Jan CR
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):735-41. PubMed ID: 16173930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.